It was admittedly much more difficult to find good drug names than bad ones, but some standouts were identified.

The price hikes come even as the Trump administration pressures pharmaceutical companies to lower costs for patients.

In the first round of direct price negotiations between Medicare and drug manufacturers, prices for 10 expensive and commonly used drugs saw price cuts between 38 percent to 79 percent compared to ...